TriSalus Life Sciences, Inc. (TLSI)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $4.00
- As of
Kresmion compiles this page from TLSI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
TriSalus Life Sciences, Inc. (TLSI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-22.
See the full TLSI dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TLSI on one page. Preview it with sample data, then open it live with a free account.
Preview the TLSI dossierActive signals for TLSI
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 21.1% - EPS $-0.27 vs $-0.2229 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 65.0% - EPS $-0.25 vs $-0.1515 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 56.4% - EPS $-0.21 vs $-0.1343 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 118.9% - EPS $0.03 vs $-0.1591 estimate
FREE, NO ACCOUNT
Every signal on TLSI, as it fires
New filings, 13F moves and cross asset signals on TLSI land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, TLSI
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
TLSI against its peers
TLSI's operating margin of -59.7% ranks in the 39th percentile of 21 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | TLSI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 45.2M USD | 85.2M USD | 30 | 21 |
| Gross margin | 84.6% | 56.0% | 93 | 21 |
| Operating margin | -59.7% | -21.1% | 39 | 21 |
| Net margin | -86.9% | -27.7% | 25 | 21 |
| Return on equity | n/a | -46.0% | n/a | 21 |
| P / E | n/a | 26.6x | n/a | 6 |
| 1 year | -12.9% | -27.9% | 57 | 21 |
Peers (22): ELMD, LAB, TMCI, CATX, INFU, CLPT, QSI, QTRX, STIM, CV, VMD, OFIX, RCEL, EBRCZ, NPCE, OWLT, SENS, MASS, TCMD, DCTH, APYX, SSII. Left out: PROF (no annual filing), MOBI (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (TLSI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow TLSI on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to TLSI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.